Non-Alcoholic Steatohepatitis (NASH) Trial

Non-Alcoholic Steatohepatitis (NASH) Trial 

Digestive Disease Associates of Rockland and Gen1 Research have partnered in a study evaluating an investigational drug for treatment of liver fibrosis in adult patients who have non-alcoholic steatohepatitis (NASH).  To qualify, participants must:

 

  • Be between the ages if 18 and 75
  • Have had liver biopsy or be willing to undergo a liver biopsy

 Qualified participants may receive:

 

  • Compensation for time & travel
  • Study-related care at no cost

 For more information, please contact our Clinical Research Coordinator, Samantha Oberdier, at (845) 367-1621 or soberdier@gen1research.com

DDAR Blog

3/11/20

 

The following is reprinted from the CCFA March 11, 2020 email blast to their provider network. 

We understand that there’s a lot of information in the news about the...

Latest News

3/31/20

Dear Patients

Your Digestive Disease Associates of Rockland Physicians and Nurse Practitioners are here to serve you and can now provide care via telehealth from the comfort and safety of...